SK
Swati Kumari
About Swati Kumari
Data last updated:
Swati Kumari is a Managing Director at Zetaca Pharmaceuticals Private Limited (since 2018). The company operates in Food And Beverages. Zetaca Pharmaceuticals Private Limited reported revenue of ₹3,951 (FY 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 11 Feb 2018 | 2018 | ₹3,951 (FY 2018) | Active |
Board colleagues of Swati Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amul Kumar Singh | 08120792 | Zetaca Pharmaceuticals Private Limited | Additional Director |
| Prince Kumar Sinha | 08067641 | Zetaca Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swati Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swati Kumari
Swati Kumari currently holds 1 directorship: Zetaca Pharmaceuticals Private Limited (Managing Director, since 11 Feb 2018, revenue ₹3,951 (FY 2018)).
Swati Kumari was first appointed on 11 Feb 2018 as Managing Director at Zetaca Pharmaceuticals Private Limited.
The current boards of Swati Kumari's companies include Amul Kumar Singh (Zetaca Pharmaceuticals Private Limited), Prince Kumar Sinha (Zetaca Pharmaceuticals Private Limited).